PALESE PETER has a total of 15 patent applications. Its first patent ever was published in 1994. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are MEDIGEN INC, IMMUNICUM AB and TECHNOVAX INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 12 | |
#2 | WIPO (World Intellectual Property Organization) | 2 | |
#3 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Climate change adaptation technologies | |
#6 | Enzymes | |
#7 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Palese Peter | 15 |
#2 | Garcia-Sastre Adolfo | 13 |
#3 | Muster Thomas | 3 |
#4 | Brownlee George G | 2 |
#5 | Webby Richard J | 2 |
#6 | Fodor Ervin | 2 |
#7 | Webster Robert G | 2 |
#8 | Richt Juergen A | 2 |
#9 | Lager Kelly M | 2 |
#10 | O'Neil Robert E | 1 |
Publication | Filing date | Title |
---|---|---|
US2006019350A1 | Recombinant negative strand RNA virus expression system and vacccines | |
WO2005009467A1 | Chris-like virus, compositions, vaccines and uses thereof | |
WO9429439A1 | High yielding influenza viruses |